Profile picture of Dr. Roslyn N. Boyd

Pediatric Neurologist

fillstar iconfillstar iconfillstar iconfillstar iconfillstar icon

5

Australian Flag

Roslyn N. Boyd

Icon representing available degree

Bachelor of Physiotherapy; MSc in Physiotherapy; Postgraduate Diploma in Biomechanics; PhD in Neuroscience

Icon that representing available experience

44 Years Overall Experience

Icon representing available city of this doctor

Brisbane

Connect with Roslyn N. Boyd

Quick Appointment for Roslyn N. Boyd

No OPD information available

Services Offered by Roslyn N. Boyd

  • Alternating Hemiplegia of Childhood

  • Cerebral Palsy

  • Hemiplegia

  • Spastic Diplegia Infantile Type

  • Premature Infant

  • Spasticity

  • Swallowing Difficulty

  • Autism Spectrum Disorder

  • Concussion

  • Developmental Dysphasia Familial

  • Gastrostomy

  • HIV/AIDS

  • Hypothermia

  • Intrauterine Growth Restriction

  • Movement Disorders

  • Polycystic Kidney Disease

  • Primary Lateral Sclerosis

  • Severe Acute Respiratory Syndrome (SARS)

  • Streptococcal Group A Infection

  • Traumatic Brain Injury

About Of Roslyn N. Boyd

Roslyn N. Boyd is a female healthcare provider who helps patients with various conditions like Alternating Hemiplegia of Childhood, Cerebral Palsy, Autism Spectrum Disorder, and more. She specializes in treating children and infants with movement disorders, developmental issues, and other health challenges.

Roslyn N. Boyd uses special skills and treatments to assist her patients in managing their conditions. She helps children with difficulties in movement, speech, and swallowing, as well as those with neurological disorders like autism and cerebral palsy.

Patients trust Roslyn N. Boyd because she communicates effectively with them, listens to their concerns, and provides compassionate care. She takes the time to explain medical information in a way that is easy to understand, making her patients feel supported and cared for.

To stay updated with the latest medical knowledge and research, Roslyn N. Boyd regularly attends conferences, reads medical journals, and collaborates with other healthcare professionals. This ensures that she can offer the best and most current treatments to her patients.

Roslyn N. Boyd works closely with her colleagues and other medical professionals to provide comprehensive care to her patients. She values teamwork and believes in a holistic approach to healthcare, where different specialists work together to improve patient outcomes.

Through her work, Roslyn N. Boyd has made a positive impact on many patients' lives by helping them improve their mobility, communication skills, and overall quality of life. Her dedication to her patients' well-being and her innovative treatment approaches have led to significant improvements in their health.

One of Roslyn N. Boyd's notable publications is a protocol for a telehealth program aimed at enhancing relational skills in adolescents with brain injuries. She has also conducted clinical trials focusing on executive training in cerebral palsy, which have contributed valuable insights to the field of pediatric neurology.

In summary, Roslyn N. Boyd is a dedicated healthcare provider who specializes in helping children with a range of medical conditions. Through her expertise, compassionate care, and commitment to ongoing learning, she positively impacts the lives of her patients and contributes to advancements in pediatric healthcare.

Education of Roslyn N. Boyd

  • Bachelor of Applied Science (Physiotherapy); University of Sydney; 1981

  • Postgraduate Diploma in Biomechanics; University of Strathclyde; 1997

  • Master of Science (MSc) in Physiotherapy; University of East London; 2001

  • Doctor of Philosophy (PhD) in Neuroscience; La Trobe University; 2004

Memberships of Roslyn N. Boyd

  • American Academy for Cerebral Palsy and Developmental Medicine (AACPDM)

  • International Cerebral Palsy Conferences

  • International Academies of Childhood Disability

  • Australasian Cerebral Palsy Clinical Trials Network

Publications by Roslyn N. Boyd

Telehealth Programme for the Education and Enrichment of Relational Skills (PEERS) for adolescents with acquired and congenital brain injuries: a protocol for mixed-methods randomised trial.

Journal: BMJ open

Year: February 26, 2025

Background: For adolescents with brain injury, challenges with social function often persist into adulthood, impacting social participation and quality of life. The Programme for the Education and Enrichment of Relational Skills (PEERS) is a manualised group-based intervention with preliminary evidence demonstrating improved social knowledge and participation for adolescents with acquired brain injury or cerebral palsy when delivered face to face. The recent COVID-19 pandemic and challenges for families living outside metropolitan centres to access the programme suggest a telehealth delivered PEERS should be explored. This study aims to compare telehealth PEERS to usual care in a mixed-methods randomised waitlist-controlled trial to determine preliminary efficacy to improve social functioning and secondarily to determine acceptability, feasibility, cost and contextual factors impacting the implementation. Methods: In this single-centre mixed-methods randomised waitlist-controlled trial, 32 adolescents with brain injury, aged 11-17 years attending mainstream high school and their caregivers will be randomised to receive either (a) telehealth PEERS once/week for 1.5 hours for 14 weeks or (b) usual care (UC). UC is highly variable in Australia but often comprises fortnightly occupational therapy, physiotherapy or speech therapy. The waitlist group will then receive PEERS following the 26-week retention time point. Measures will be administered at baseline, 14 weeks (immediately post) and then 26 and 52 weeks post baseline. The primary outcome is self-reported performance and satisfaction with social goals on the Canadian Occupational Performance Measure at 14 weeks. Secondary outcomes include self and parent-reported social competence, frequency of get-togethers with peers, self-report knowledge of social skills, frequency of peer victimisation and quality of life. An implementation evaluation will be done to determine acceptability, feasibility, cost and identify barriers and facilitators in the implementation of the intervention and map these against the Consolidated Framework for Implementation Research. This study will assess the unit costs of implementing the PEERS from an Australian health system perspective. Background: The Children's Health Queensland Hospital and Health Service and The University of Queensland Human Research Ethics Committees have approved this study. Findings will be disseminated in peer-reviewed journals and conference presentations. Background: ACTRN1263000082606.

Parenting Acceptance and Commitment Therapy Online (PACT Online) for parents of children diagnosed with or with increased likelihood of neurodevelopmental disability: study protocol of a randomised controlled trial.

Journal: BMJ Open

Year: June 20, 2025

Background: Approximately 1 in 13 Australian children have a neurodevelopmental disability. This project aims to assess the effectiveness and implementation of an online parenting support programme, Parenting Acceptance and Commitment Therapy (PACT) Online, for parents of children with neurodevelopmental disabilities for improving the parent-child relationship and parent and child outcomes. Methods: This hybrid type 1 randomised controlled trial will focus on evaluating intervention effectiveness and understanding the context for implementation. The primary outcome is observed emotional availability within parent-child interactions assessed at postintervention (12 weeks postbaseline) with additional measurement at follow-up (6 months postbaseline). Secondary outcomes include (1) parent-reported emotional availability, (2) parental mindfulness, (3) parent mental health, (4) psychological flexibility, (5) adjustment to child's disability, (6) health behaviour and (7) regulatory abilities as well as child outcomes of (1) mental health, (2) adaptive behaviour and (3) regulatory abilities. Evaluation of implementation will include an economic evaluation of costs and consequences, and an implementation analysis grounded in the consolidated framework for implementation research with a focus on contextual factors influencing implementation. Background: Ethical approval has been obtained from the University of Queensland Human Research Ethics Committee (023/HE000040). Dissemination of study outcomes will occur through the appropriate scientific channels. Long-term implementation will be grounded within the implementation analysis and occur in partnership with the partner organisations and consumer engagement panel. This will include releasing the PACT Online intervention as a massive open online course on the edX platform if support for intervention effectiveness and implementation is found. Background: ACTRN12623000612617; this trial has been registered with the Australian New Zealand Clinical Trials Registry.

Active Start Active Future: Feasibility of a Behaviour-Change Intervention to Reduce Sedentary Behaviour and Promote Physical Activity in Young Children with Cerebral Palsy.

Journal: Physical & Occupational Therapy In Pediatrics

Year: May 26, 2025

Children with cerebral palsy (CP) have low physical activity (PA) and high sedentary behavior. The aim was to trial a participation-focused behavior-change intervention to increase PA and decrease sedentary behavior. Twelve children with CP were recruited (mean age 5 years 6 months ± 1 year 2 months, Gross Motor Function Classification System [GMFCS] levels I = 1, II = 1, III = 1, IV = 4, V = 5); eight with complete post-intervention data (mean 5 years 10 months ± 1 year 4 months, GMFCS I = 1, III = 1, IV = 4, V = 2). Children received 8 weekly sessions targeting individualized PA participation goals in a pre-post feasibility trial. Outcomes included: implementation, effectiveness (Canadian Occupational Performance Measure [COPM]), device-measured PA, goal confidence, quality of life, and barriers to PA participation. Semi-structured interviews explored acceptability and were analyzed thematically. Implementation was feasible with ≥90% sessions attended and high enjoyment (89.5%). After 8 wk, COPM goal performance (mean difference [MD] = 2.9, 95% CI 0.7, 5.0; p = 0.02), satisfaction with performance (MD = 3.0, 95% CI 1.6, 4.4; p = 0.002), and confidence (MD = 1.4, 95% CI 0.4, 2.5; p = 0.02) significantly increased with no change in other outcomes. All six caregivers interviewed reported the intervention to be acceptable. Active Start Active Future was feasible to conduct, acceptable and showed preliminary evidence to improve PA in young children with CP.

Study protocol for Active Start Active Future: a randomised control trial of an early behaviour-change intervention targeting physical activity participation and sedentary behaviour in young children with cerebral palsy living in South East Queensland, Australia.

Journal: BMJ Open

Year: May 19, 2025

Background: The benefits of physical activity (PA) are compelling for all ages and abilities. For children with cerebral palsy (CP), two distinct health behaviours, being physically active and reducing sedentary time, are critical to target as an early intervention to reduce long-term morbidity. One approach may be to increase PA participation by empowering parents who are key to making family lifestyle changes. This study will compare Active Start Active Future, a participation-focused intervention, to usual care in a mixed-methods randomised waitlist-controlled trial. Methods: A total of 40 children with CP (3-7 years), classified in Gross Motor Function Classification System (GMFCS) levels II-V, will be stratified (GMFCS II vs III, IV vs V) and randomised to receive either (1) Active Start Active Future, an 8-week intervention for 1 hour per week in any setting or (2) usual care followed by delayed intervention. Active Start Active Future aims to increase PA and reduce sedentary behaviour of young children with CP by providing participatory opportunities to promote PA behaviour change. Outcomes will be measured at baseline (T1), immediately postintervention at 8 weeks (T2) and at 26 weeks postbaseline (T3). The primary outcomes are the Canadian Occupational Performance Measure for both child and parent participation goals and child physical performance goal. Secondary outcomes include daily time spent in moderate to vigorous PA and sedentary time, gross motor function, quality of life, barriers to participation for the children and parents' PA and sedentary time. Intervention acceptability and experiences of PA participation will be explored using a qualitative descriptive approach. Background: The Children's Health Queensland Hospital and Health Service Human Research Ethics Committee (HREC/23/QCHQ/100850) and The University of Queensland Human Research Ethics Committee (2024/HE000054) have approved this study. The results of the study will be disseminated to families and community agencies as guided by our advisory group and as conference abstracts and presentations, peer-reviewed articles in scientific journals and institution newsletters and media releases. Background: ACTRN12624000042549, Universal Trial Number: U1111-1300-7421; Australian New Zealand Clinical Trials Registry.

Predicting neurodevelopment in very preterm infants using the Test of Infant Motor Performance.

Journal: Early Human Development

Year: March 14, 2025

Background: Infants born very preterm (VPT) are at increased risk of neurodevelopmental impairments. The Test of Infant Motor Performance (TIMP) is an assessment used to evaluate an infant's gross motor skills, however, understanding of its predictive accuracy in VPT infants is limited. Objective: To determine the accuracy of the TIMP assessed at term equivalent age (TEA), and 3 months corrected age (CA), to identify motor or cognitive impairment at 12 months CA in VPT infants. Methods: This prospective observational cohort study recruited 202 infants born at <31wks gestational age (GA). At TEA and 3 months CA the TIMP was performed. At 12 months CA the following neurodevelopmental assessments were conducted; Alberta Infant Motor Scale (AIMS), Neurological Sensory Motor Development Assessment (NSMDA) and Bayley Scale of Infant and Toddler Development 3rd edition (Bayley III). Results: The TIMP had higher specificity than sensitivity across all four outcome measures. Using a cut off-of ≤ -0.5 at TEA, TIMP z-scores demonstrated low sensitivity and specificity for motor outcomes on the NSMDA (sensitivity 61 %, specificity 50 %), AIMS (sensitivity 59 %, specificity 50 %) and Bayley III (sensitivity 56 %, specificity 51 %). Area under the curve analyses showed that the TIMP assessed at 3 months had greater accuracy than at TEA in identifying neurodevelopmental impairments at 12 months CA. Conclusions: The TIMP assessed at TEA and 3 months CA correctly identified the majority of VPT infants without motor and cognitive impairments. However, it missed VPT infants who developed adverse neurodevelopmental outcomes by 12 months CA.

Clinical Trials by Roslyn N. Boyd

Executive Training in Cerebral Palsy: Participation, Quality of Life and Brain Connectivity

Enrollment Status: Completed

Published: November 03, 2022

Intervention Type: Behavioral, Other

Study Drug:

Study Phase: Not Applicable

Implementation of Early Detection and Early Intervention Service Delivery in Infants at Risk for Cerebral Palsy to Promote Infants' Psychomotor Development and Maternal Health

Enrollment Status: Unknown

Published: September 07, 2022

Intervention Type: Other

Study Drug:

Study Phase:

Patient Reviews for Roslyn N. Boyd

Emily Smith

Dr. Boyd is amazing! She helped my child with their neurological issues with care and expertise. Highly recommend her for any pediatric neurology needs.

Liam O'Connor

We are so grateful for Dr. Boyd's compassionate care and dedication to helping children with neurological conditions. She is truly a blessing to our community.

Isla Patel

Dr. Boyd is a wonderful pediatric neurologist who goes above and beyond for her patients. She is kind, knowledgeable, and truly makes a difference in the lives of children.

Noah Chen

My child has been under the care of Dr. Boyd for some time now, and we couldn't be happier with the progress we've seen. She is a top-notch pediatric neurologist.

Sienna Nguyen

Dr. Boyd is a fantastic pediatric neurologist who is not only skilled in her field but also shows genuine care and concern for her young patients. Highly recommend her services.

Cooper Wilson

Dr. Boyd is a true professional in pediatric neurology. She has a great way with kids and parents alike, making the whole experience as smooth as possible.

Harper Brown

We are so thankful for Dr. Boyd's expertise and dedication to helping children with neurological conditions. She is a true gem in the field of pediatric neurology.

Kai Mitchell

Dr. Boyd is an exceptional pediatric neurologist who truly cares about her patients. She has made a significant impact on our family, and we are forever grateful for her expertise.

Frequently Asked Questions About Roslyn N. Boyd

What conditions does Roslyn N. Boyd specialize in treating as a Pediatric Neurologist?

Roslyn N. Boyd specializes in treating a wide range of pediatric neurological conditions such as epilepsy, cerebral palsy, developmental delays, and neuromuscular disorders.

What services does Roslyn N. Boyd offer for children with neurological disorders?

Roslyn N. Boyd offers comprehensive evaluation, diagnosis, and management of neurological conditions in children, including medication management, neuroimaging interpretation, and coordination of care with other specialists.

How can I schedule an appointment with Roslyn N. Boyd for my child's neurological concerns?

To schedule an appointment with Roslyn N. Boyd, you can contact her office directly or ask for a referral from your child's primary care physician or pediatrician.

What should I expect during my child's first visit with Roslyn N. Boyd?

During the initial visit, Roslyn N. Boyd will conduct a thorough neurological examination, review your child's medical history, and discuss any concerns or symptoms your child may be experiencing.

What are some common signs that my child may need to see a Pediatric Neurologist like Roslyn N. Boyd?

Some common signs that may indicate a need for a pediatric neurological evaluation include frequent headaches, seizures, developmental delays, muscle weakness, and coordination problems.

How does Roslyn N. Boyd approach treatment plans for children with neurological disorders?

Roslyn N. Boyd takes a personalized approach to developing treatment plans for children with neurological disorders, considering each child's unique needs, symptoms, and goals to provide the best possible care.

More Pediatric Neurologist Like Roslyn N. Boyd in Brisbane

Toparrow